Latest Incentive Plans News

Podium Minerals has appointed mining heavyweight Neal Froneman as Non-Executive Chairman, alongside key executive promotions, setting the stage for accelerated development of its Parks Reef PGM Project in Western Australia.

Pursuit Minerals has successfully completed the first tranche of a $7 million placement, issuing nearly 47 million shares at 9.5 cents each, with a second tranche and incentive options pending shareholder approval.

FortifAI Limited has completed its acquisition of FastAI Pty Ltd, gaining control of the innovative Nol8 technology and appointing seasoned executive Yosef Keret as director and Celerriem CEO.

Battery Age Minerals has appointed Sebastian Kneer as its new CEO, bringing nearly two decades of global exploration expertise. His leadership comes with a performance-linked incentive plan aimed at driving shareholder value.

Pioneer Minerals has varied CEO Michael Beven’s employment terms, proposing a fresh grant of 1.2 million Performance Rights under a new Employee Share Incentive Plan, pending shareholder approval in March 2026.

DroneShield Limited has triggered the vesting of over 9 million performance options following a significant $200 million cash receipts milestone, reflecting rapid growth and a new incentive framework.

Eminence Minerals has appointed Anthony Hills as CEO, bringing over 16 years of global operational expertise to accelerate its exploration and project development efforts.

Proteomics International Laboratories has appointed David Morris as CEO and Managing Director, marking a strategic shift towards commercialising its Promarker® diagnostic technology. Morris brings extensive global healthcare leadership experience to lead the company’s next growth phase.

Bayan Mining has appointed Nathan Kong as its new CEO, bringing over 17 years of tier-one mining experience to lead its rare earth projects and strategic growth initiatives.

Estrella Resources appoints Robert Mencel as CEO, transitioning to Managing Director by mid-2026, to spearhead its limestone and manganese projects in Timor-Leste. The leadership reshuffle aims to accelerate development and operational ramp-up.

Opthea Limited has announced a strategic pivot to develop OPT-302 for Lymphangioleiomyomatosis (LAM), a rare lung disease affecting women, aiming for ASX reinstatement in 2026. The company leverages strong intellectual property and cash reserves to pursue orphan drug designation and clinical development.

Boom Logistics has appointed Lester Fernandez as its permanent Managing Director and CEO, entrusting him to lead the company through its next phase of growth with a strong focus on safety and operational excellence.